Cuts to U.S. funding for HIV programs could have dire consequences, according to Winnie Byanyima, the Executive Director of UNAids. She warned that these cuts might lead to an alarming increase of 2,000 new HIV infections each day and over six million additional deaths over the next four years. This stark warning highlights a potential reversal in the progress made against HIV, which has seen deaths drop from over two million in 2004 to around 600,000 in 2023.
Byanyima noted that the pause in foreign aid, announced by U.S. President Donald Trump shortly after he took office, is already having serious repercussions. Many HIV treatment and prevention programs have been halted, leading to the closure of clinics and severe shortages of critical anti-retroviral medications. She emphasized that women and girls are particularly affected by these funding cuts.
The U.S. has historically been the largest supporter of HIV treatment and prevention worldwide. Byanyima expressed her gratitude for past U.S. contributions but urged the government to reconsider the abrupt withdrawal of support. She suggested that while it is reasonable for the U.S. to reduce funding over time, the sudden cuts are causing immediate harm.
The impact of the funding pause is being felt across several countries. The World Health Organization (WHO) has identified eight nations, including Nigeria and Kenya, that are at risk of running out of HIV drugs. WHO chief Tedros Adhanom Ghebreyesus warned that the disruption could undo two decades of progress in the fight against HIV.
Byanyima shared the story of Juliana, a young woman in Kenya who worked for a U.S.-funded program that helped new mothers access HIV treatment. With the program suspended, Juliana is now out of work and fears losing her own treatment while breastfeeding her child.
In response to the crisis, Byanyima proposed a partnership with the Trump administration to market a new HIV drug developed by a U.S. company. This drug, Lenacapavir, could potentially benefit millions and generate profits and jobs in the U.S.
UNAids is not the only UN agency facing funding challenges; other organizations, such as UNICEF and the World Food Programme, are also grappling with cuts that threaten vital services. As traditional aid donors in Europe plan their own funding reductions, the future of HIV treatment and prevention programs hangs in the balance.